Lauren Abrams, MD
Urology · Denver, CONPI 1225558810
Payments from drug & device makers
Across 51 payments — averaging $74.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Coloplast$1K
- Laborie Medical Technologies Corp.$117
- Photocure Inc$77
- C. R. Bard, Inc. & Subsidiaries$74
- Axonics, Inc.$74
- plus $253 from 11 others
What the payments were for
- Travel & lodging$1,92451%
- Food & beverage$1,86549%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $1,748 |
| Coloplast | 9 | $1,446 |
| Laborie Medical Technologies Corp. | 2 | $117 |
| Photocure Inc | 1 | $77 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $74 |
| Axonics, Inc. | 1 | $74 |
| Teleflex LLC | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Medtronic | 1 | $24 |
| Convatec Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $23 |
| Rochester Medical Corporation | 1 | $22 |
| Merck | 1 | $22 |
| Tolmar, Inc. | 1 | $21 |
| 180 Medical, Inc. | 1 | $20 |
| Pfizer | 1 | $20 |
| Urogen Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$1,178
- AMS 700 CXR RTE KIT$126
How this compares
$3,789 in reported general payments places this provider in the 55th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 109 | $69,497 |
| Methenamine Hippurate | 148 | $12,268 |
| Fosfomycin Tromethamine | 22 | $4,034 |
| Tamsulosin Hcl | 240 | $2,859 |
| Estradiol | 33 | $2,365 |
| Solifenacin Succinate | 45 | $1,734 |
| Finasteride | 133 | $1,604 |
| Trospium Chloride | 17 | $1,559 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $442 |
| CefuroximeCefuroxime Axetil | 23 | $418 |
| Ciprofloxacin Hcl | 41 | $353 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $249 |
| Oxybutynin Chloride | 32 | $230 |
| Oxybutynin Chloride ErOxybutynin Chloride | 20 | $192 |
| Levofloxacin | 28 | $140 |
Paid to pharmacies, not to this prescriber.
Other urology in Denver
- Lawrence KarshDenver$9.7M
- Elizabeth SnyderDenver$53K
- Juan MontoyaDenver$50K
- Elias HsuDenver$23K
- John TillettDenver$21K
- Milford PainterDenver$13K
- Nina CasanovaDenver$12K
- Julien DagenaisDenver$11K
- Stephen RuyleDenver$9K
- Brian SmithDenver$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.